Abstract | BACKGROUND: AIMS: METHODS: 10 gastric and 22 oesophageal adenocarcinoma archival samples were randomly selected from a database. The presence of ghrelin-positive cells was assessed in cancer and corresponding non-neoplastic mucosa by immunohistochemistry. Quantitative reverse transcriptase polymerase chain reaction (PCR) for ghrelin mRNA was also performed on 24 gastric and 8 oesophageal adenocarcinoma specimens and adjacent non-neoplastic mucosa. RESULTS: Immunohistochemistry and reverse transcriptase PCR confirm a negligible expression of ghrelin in adenocarcinoma specimens. By contrast, non-neoplastic gastric mucosa was rich in ghrelin-positive cells and ghrelin mRNA. The number (median and range) of ghrelin-positive cells per 2 mm section of non-neoplastic mucosa was 73 (45-215) in the corpus; this was significantly higher than in cardia mucosa (9 (0-64), p<0.001) and antral mucosa (5 (0-14), p<0.001). CONCLUSIONS: Gastric and oesophageal adenocarcinomas have no ghrelin-producing cells. The highest level of ghrelin expression was noted in the non-neoplastic mucosa of the gastric corpus. Disruption of the gastric ghrelin-producing mechanism may occur during oesophagogastric malignancy.
|
Authors | Marcus Mottershead, Emmanuel Karteris, Jill Y Barclay, Saira Suortamo, Mark Newbold, Harpal Randeva, Chuka U Nwokolo |
Journal | Journal of clinical pathology
(J Clin Pathol)
Vol. 60
Issue 4
Pg. 405-9
(Apr 2007)
ISSN: 0021-9746 [Print] England |
PMID | 16751299
(Publication Type: Journal Article)
|
Chemical References |
- Ghrelin
- Peptide Hormones
- RNA, Messenger
- RNA, Neoplasm
|
Topics |
- Adenocarcinoma
(metabolism)
- Esophageal Neoplasms
(metabolism)
- Gastric Mucosa
(metabolism)
- Ghrelin
- Humans
- Immunoenzyme Techniques
- Neurosecretory Systems
(metabolism)
- Peptide Hormones
(biosynthesis, genetics)
- RNA, Messenger
(genetics)
- RNA, Neoplasm
(genetics)
- Reverse Transcriptase Polymerase Chain Reaction
(methods)
- Stomach Neoplasms
(metabolism)
|